Drug intelligence / Profile preview

azadirachta indica leaves extract

Development stage
Phase 3
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Azadirachta indica leaves extract is a botanical preparation derived from the leaves of the Azadirachta indica tree, commonly known as neem. Neem is native to the Indian subcontinent and has been used for centuries in traditional medicine systems such as Ayurveda and Unani. The leaf extract contains over 140 bioactive compounds including nimbin, nimbidin, nimbolide, quercetin, ß-sitosterol, limonoids (such as azadirachtin), and others[1][4][6]. These constituents confer a wide range of pharmacological activities. Mechanistically, neem leaf extracts exhibit immunomodulatory effects by modulating immune responses; anti-inflammatory activity through inhibition of inflammatory mediators; antioxidant properties by scavenging free radicals; antimicrobial actions against bacteria and fungi via disruption of microbial cell walls or metabolic pathways; antihyperglycemic effects by influencing insulin secretion and glucose metabolism; antiulcer activity through mucosal protection and reduction of gastric acidity; antimalarial action via interference with parasite development; antiviral properties (including inhibition of viral DNA polymerase); antimutagenic effects that may reduce genetic mutations; anticancer potential through modulation of cell proliferation pathways[1][2][3][4][5][6]. Neem leaf extracts are used for various indications including wound healing (by promoting tissue regeneration), oral health (reducing dental plaque/gingivitis), skin diseases (antimicrobial/anti-inflammatory), diabetes management (lowering blood sugar levels), fever reduction (antipyretic effect), gastrointestinal ulcers (antiulcerogenic effect), arthritis/joint inflammation relief, blood purification/detoxification support[1][2][3][4][5]. However, most uses are based on traditional practice or preclinical studies—robust clinical evidence remains limited.

Other names
neem leaf extractneem leaves extractAzadirachta indica leaf extractIndian lilac leaf extract
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)TNFA (Tumor necrosis factor alpha (soluble))PEPCK (Phosphoenolpyruvate carboxykinase 1)

Beyond the preview

Go deeper on azadirachta indica leaves extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on azadirachta indica leaves extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call